Trade PGEN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Precigen, Inc. (PGEN) is trading at US$6.95, down 3.41% today as of Aug 28, 12:35 EDT. The company has a market capitalisation of US$2.58B. Over the past 52 weeks, PGEN has traded between US$2.99 and US$7.72. On Syfe you can trade PGEN with $0 commission and add it to your watchlist.
| Previous close | US$7.19 |
|---|---|
| Market cap | US$2.58B |
| P/E ratio | 13.97 |
| 52-week range | US$2.99 – US$7.72 |
| Volume | 4.97M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Precigen, Inc.
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
Year: 2013
Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing
Jul 2, 8:14 AM · MT Newswires
Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing
Jul 2, 8:13 AM · MT Newswires
Precigen, Inc. (PGEN) stock is trading at US$6.95, -3.41% from the previous close of US$7.19.
The market cap for Precigen, Inc. (PGEN) stock is approximately US$2.58B.
The price-to-earnings ratio for Precigen, Inc. (PGEN) is 13.97, based on the latest reported earnings.
The 52-week high for Precigen, Inc. (PGEN) stock is US$7.72.
The 52-week low for Precigen, Inc. (PGEN) stock is US$2.99.
Precigen, Inc. (PGEN) does not currently pay a dividend.
Stay on top of PGEN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
